Nipah Virus: First Human Trial For Deadly Infection Vaccine Begins
[ad_1] Fifty-one people aged 18 to 55 will participate in the trial of the ChAdOx1 NipahB vaccine, developed by researchers at the University of Oxford’s Pandemic Sciences Institute, the varsity said in a statement. Nipah virus is a devastating disease that can be fatal in around 75 per cent of cases. Outbreaks have occurred in…